FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TOFACITINIB CITRATE
异名/同义词1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)
CP-690
CP-690,550-10
CP-690550 CITRATE
CP-690550-10
TASOCITINIB CITRATE
TASOCITINIB MONOCITRATE
TOFACITINIB CITRATE
TOFACITINIB CITRATE [JAN]
TOFACITINIB CITRATE [ORANGE BOOK]
TOFACITINIB CITRATE [USAN]
TOFACITINIB CITRATE [WHO-DD]
TOFACITINIB MONOCITRATE [MI]
XELJANZ
XELJANZ XR
CAS登记号540737-29-9
物质唯一标识(Unique Ingredient Identifier)O1FF4DIV0D
分子式
国际化合物标识(International Chemical Identifier,InChI)WW-12
SMILESC16H20N6O.C6H8O7
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型SYIKUFDOYJFGBQ-YLAFAASESA-N / [C@H]1(CCN(C[C@@H]1N(C)c2c3c(ncn2)[nH]cc3)C(=O)CC#N)C.OC(CC(CC(=O)O)(O)C(=O)O)=O
关联数据
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System